Episodes List
S18 Ep38: Fast-Moving Treatment Advances Shape B-Cell Lymphoma Care
17 Sep, 2026S18 Ep37: Metastatic Non-Small Cell Lung Cancer 2026 UPDATE
14 Sep, 2026S18 Ep36: Precision Immunotherapy, PET-Adapted Regimens, and Novel Targets Are Redefining Hodgkin Lymphoma Care: With Chandler Park, MD; Joshua Brody, MD
14 Sep, 2026S18 Ep35: The ADC Revolution in Metastatic Breast Cancer: Redefining Treatment Selection and Sequencing
11 Sep, 2026S18 Ep33: Current Approaches and Future Directions for Early-Stage TNBC
04 Sep, 2026S18 Ep32: Non–Small Cell Lung Cancer 2026 UPDATE
31 Aug, 2026S18 Ep31: FDA Approval Insights: Integrating RP1 Plus Nivolumab Into Post–PD-1 Melanoma Practice: With Michael K. Wong, MD, PhD, FRPC
28 Aug, 2026S18 Ep31: Immunotherapy Decision-Making in CSCC Sits at the Intersection of Efficacy and Comorbidity: With Eric D. Whitman, MD; and Francis Paul Worden, MD
28 Aug, 2026S18 Ep30: FDA Approval Insights: Iberdomide-Based Therapy Adds Another Option for R/R Myeloma: With Sagar Lonial, MD, FACP, FASCO
27 Aug, 2026S18 Ep29:
24 Aug, 2026S18 Ep28: Pancreatic Cancer Treatment Advances Call for a Renewed Focus on the Role of Liposomal Irinotecan: With Jennifer B. Valerin, MD, PhD
20 Aug, 2026S18 Ep27: Key Considerations for Health Equity and Patient-Centered Care in TNBC
17 Aug, 2026S18 Ep26: FDA Approval Insights: Gedatolisib Plus Fulvestrant ± Palbociclib for HR+, HER2-Negative, PIK3CA Wild-Type Advanced Breast Cancer: With Adam M. Brufsky, MD, PhD
14 Aug, 2026S18 Ep25: Greater Flexibility and Improved QOL Represent Key Potential Benefits With Liquid TKI Formulations: With Jonathan Trent, MD, PhD
07 Aug, 2026S18 Ep24: Precision Oncology, Bispecific Antibodies, and Next-Generation Targeted Therapies Are Reshaping NSCLC Care: With Chandler Park, MD; Stephen V. Liu, MD
04 Aug, 2026S18 Ep23: From Trials to the Clinic: Incorporating New Advances in Metastatic TNBC
03 Aug, 2026S18 Ep22: FDA Approval Insights: Subcutaneous Isatuximab Via an On-Body Delivery System Represents a “Game-Changer” in Multiple Myeloma: With Douglas W. Sborov, MD, MS
31 Jul, 2026S18 Ep21: Positioning PD-L1/VEGF Bispecifics in First-Line Non–Small Cell Lung Cancer: With Solange Peters, MD, PhD
31 Jul, 2026S18 Ep20: Biomarker-Driven Shifts Signal the Next Generation of mCRC Therapies: With Tanios S. Bekaii-Saab, MD
30 Jul, 2026S18 Ep19: Navigating Fixed-Durations Regimens in CLL and Improving Outcomes for High-Risk Patients: With John N. Allan, MD
30 Jul, 2026S18 Ep18: Sequencing Systemic and Liver-Directed Therapy in HLA-A*02:01–Negative Metastatic Uveal Melanoma: With Marlana M. Orloff, MD
29 Jul, 2026S18 Ep17: Experts Bridge Oncology and Neurology to Catch LEMS Earlier in SCLC: With Misty D. Shields, MD, PhD; Triparna Sen, MD, PhD, MS; and Ditte Primdahl, MD
29 Jul, 2026S18 Ep16: FDA Approval Insights: Orca-T Raises the Bar for Allogeneic Transplants in Hematologic Malignancies: With Everett Meyer, MD, PhD
28 Jul, 2026S18 Ep15: ASCO 2026 ADC Data Clarify Some Strategies and Raise Further Questions for Breast Cancer Care: With Paolo Tarantino, MD, PhD
28 Jul, 202642: Neel on Maximizing Research Strides in Oncology
16 Sep, 202141: Loaiza-Bonilla Offers Guidance on Optimizing Treatment Selection in Pancreatic Cancer
13 Sep, 202140: Lisberg Discusses the Promise of Datapotamab Deruxtecan in Lung Cancer
09 Sep, 202139: McKay Filters Through Frontline Treatment Considerations in mRCC
06 Sep, 202138: Sosa Talks Risk Factors, Rising Incidence, and Controversies in Thyroid Cancer
02 Sep, 2021